News Headlines Article

America’s broken healthcare has fallen off the radar. Here’s why we can’t afford to let that happen

Last September, when so-called “pharma bro” Martin Shkreli was revealed to be the CEO of a drug company that had increased the price of a 62-year old medicine commonly used by AIDS patients by more than 5,000 percent, Republicans and Democrats had finally found something to agree on. What followed was bipartisan disdain for the former hedge-fund manager. Donald Trump remarked that Shkreli looked like a “spoiled brat,” while Hillary Clinton said that if he was going to try to gouge American families “for no good reason” — as if there is any good reason — then she was going to hold him “accountable.”